These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 32004875)
1. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia? Boulware R; Refaai MA Thromb Res; 2020 Mar; 187():154-158. PubMed ID: 32004875 [TBL] [Abstract][Full Text] [Related]
2. Platelet microparticles in immune thrombocytopenic purpura in pediatrics. Tantawy AA; Matter RM; Hamed AA; Shams El Din El Telbany MA Pediatr Hematol Oncol; 2010 May; 27(4):283-96. PubMed ID: 20426519 [TBL] [Abstract][Full Text] [Related]
3. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Sewify EM; Sayed D; Abdel Aal RF; Ahmad HM; Abdou MA Thromb Res; 2013 Feb; 131(2):e59-63. PubMed ID: 23245653 [TBL] [Abstract][Full Text] [Related]
4. Clinical variations between three different causes of thrombocytopenia. Akin S; Haznedaroglu IC Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020 [TBL] [Abstract][Full Text] [Related]
5. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia. Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661 [TBL] [Abstract][Full Text] [Related]
7. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk. McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855 [TBL] [Abstract][Full Text] [Related]
8. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Frelinger AL; Grace RF; Gerrits AJ; Berny-Lang MA; Brown T; Carmichael SL; Neufeld EJ; Michelson AD Blood; 2015 Aug; 126(7):873-9. PubMed ID: 26138687 [TBL] [Abstract][Full Text] [Related]
9. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Cohen YC; Djulbegovic B; Shamai-Lubovitz O; Mozes B Arch Intern Med; 2000 Jun; 160(11):1630-8. PubMed ID: 10847256 [TBL] [Abstract][Full Text] [Related]
10. Risk-based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP). Lambert C; Maitland H; Ghanima W Eur J Haematol; 2024 Apr; 112(4):504-515. PubMed ID: 38088207 [TBL] [Abstract][Full Text] [Related]
11. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Neunert C; Noroozi N; Norman G; Buchanan GR; Goy J; Nazi I; Kelton JG; Arnold DM J Thromb Haemost; 2015 Mar; 13(3):457-64. PubMed ID: 25495497 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia. Adelborg K; Kristensen NR; Nørgaard M; Bahmanyar S; Ghanima W; Kilpatrick K; Frederiksen H; Ekstrand C; Sørensen HT; Fynbo Christiansen C J Thromb Haemost; 2019 Jun; 17(6):912-924. PubMed ID: 30933417 [TBL] [Abstract][Full Text] [Related]
13. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study. Li S; Molony JT; Cetin K; Wasser JS; Altomare I Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715 [TBL] [Abstract][Full Text] [Related]
14. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients. Tsuda H; Tsuji T; Tsuji M; Yamasaki H Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759 [TBL] [Abstract][Full Text] [Related]
15. Comparative study between two bleeding grading systems of immune thrombocytopenia purpura. Chen Q; Zhang Y; Li Y; Zhang L; Shi W; Tao H; Chen K; He Z; Wang C; Yu L Hematology; 2021 Dec; 26(1):769-774. PubMed ID: 34565307 [TBL] [Abstract][Full Text] [Related]
16. Management of major bleeds in patients with immune thrombocytopenia. Mithoowani S; Cervi A; Shah N; Ejaz R; Sirotich E; Barty R; Li N; Nazy I; Arnold DM J Thromb Haemost; 2020 Jul; 18(7):1783-1790. PubMed ID: 32219982 [TBL] [Abstract][Full Text] [Related]
17. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia. Zhou F; Xu Y; Zhang Z; Wu X; Jin R J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457 [TBL] [Abstract][Full Text] [Related]
18. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry. Sokal A; de Nadaï T; Maquet J; Comont T; Limal N; Michel M; Beyne-Rauzy O; Godeau B; Adoue D; Mahévas M; Moulis G; Br J Haematol; 2022 Mar; 196(5):1262-1270. PubMed ID: 34738634 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan. Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469 [TBL] [Abstract][Full Text] [Related]
20. Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center. Karakurt N; Uslu İ; Albayrak C; Tomak L; Ozyazici E; Albayrak D; Aygun C Blood Coagul Fibrinolysis; 2018 Sep; 29(6):546-550. PubMed ID: 30036278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]